NMS · Medical - Devices

CVRx, Inc. (CVRX) Stock

$1.42 +3.65% NMS: CVRX Healthcare

Valuation

MetricValue
Price$1.42
Market Cap$37.83M
P/E Ratio-0.78
P/B Ratio2.06
P/S Ratio0.67
EPS (TTM)$0.00
52-Week High$11.30
52-Week Low$1.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-152.35%
ROA-56.31%
ROCE-59.93%
Gross Margin-89.47%
Operating Margin-89.47%
Net Margin-84.93%
Debt/Equity2.98
Current Ratio7.85

Annual Financials (USD)

Metric20212022202320242025
Revenue$13.0M$22.0M$39.0M$51.0M$57.0M
Operating Profit$-26.0M$-43.0M$-43.0M$-59.0M$-51.0M
Net Profit$-43.0M$-41.0M$-41.0M$-60.0M$-53.0M
EPS$-2.11$-2.02$-1.99$-2.65$-2.04
Op Margin-199.2%-189.3%-109.7%-116.0%-90.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$153.0M$125.0M$115.0M$133.0M$105.0M
Total Liabilities$7.0M$16.0M$39.0M$62.0M$65.0M
Cash$142.0M$106.0M$91.0M$106.0M$76.0M
Borrowings$0$7.0M$31.0M$50.0M$51.0M

Latest News

CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last? Zacks · Jun 29, 2026 CVRx Announces Chief Financial Officer Transition GlobeNewswire · Jun 9, 2026 CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire · May 27, 2026 CVRx to Present at the William Blair 46th Annual Growth Stock Conference GlobeNewswire · May 20, 2026 CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy Zacks · May 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-43.0M$-39.0M$-39.0M$-40.0M
Investing Cash Flow$-2.0M$-1.0M$-1.0M$-3.0M$-1.0M
Financing Cash Flow$0$-1.0M$0$3.0M$0
Net Cash Flow$83.0M$-36.0M$-16.0M$15.0M$-30.0M
Free Cash Flow$-29.0M$-43.0M$-40.0M$-41.0M$-41.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.13
EV / EBITDA-0.80
FCF Yield-99.81%
Quick Ratio6.87
Interest Coverage-8.07
Return 1Y-29.80%
Return 3Y-67.79%
Return 5Y-74.08%

Ownership

Insiders Held9.55%
Institutions Held63.58%
Institutions Float Held70.29%
Institutional HolderSharesReport Date
Johnson & Johnson4,024,8612026-03-31
NEA Management Company, LLC2,026,0832026-03-31
Blackrock Inc.1,026,5592026-03-31
GSK plc1,007,5832026-03-31
Vanguard Capital Management LLC911,3102026-03-31

About CVRx, Inc.

CVRx, Inc. is led by CEO Kevin Hykes, employs 206 people, headquartered in US, publicly traded since 2021.

CVRx, Inc. (CVRX) stock trades at $1.42 with a market capitalization of $37.83M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.78, reflecting a net loss over the last twelve months, price-to-book of 2.06, price-to-sales of 0.67. Over the past 52 weeks the stock has ranged between $1.27 and $11.30, and currently trades 87.4% below its 52-week high.

On profitability, CVRx, Inc. generates a return on equity (ROE) of -152.35% (negative, reflecting a net loss), return on capital employed of -59.93%, an operating margin of -89.47%, a net profit margin of -84.93%.

CVRx, Inc. by the numbers, 2019–2025

Between 2019 and 2025 CVRx, Inc. reported revenue of $6.0M rising to $57.0M, a change of +850.0% across 7 years. Compounded, revenue has grown 56.9% a year over five years, 37.4% over three, 11.8% over the last twelve months. Net profit fell to $-53.0M.

Operating margin went from -162.9% in 2019 to -90.5% in 2025, a gain of 72.4 percentage points. The most recent net margin is -84.93%. On a trailing twelve-month basis to Jun '26, revenue is $62.0M and net profit $-52.0M.

Borrowings rose from $19.0M to $51.0M, cash from operations was $-40.0M in the latest year, positive in 0 of the last 7.

Return on equity has averaged -68.3% over five years, and was -135.9% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

CVRx, Inc. (CVRX) — frequently asked questions

What is CVRx, Inc. (CVRX) stock price today?

CVRx, Inc. (CVRX) is currently trading at $1.42, up 3.65% today.

What is CVRX P/E ratio?

CVRx, Inc.'s P/E ratio is -0.78. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CVRX return on equity (ROE)?

CVRx, Inc.'s return on equity (ROE) is -152.35%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is CVRx, Inc.'s market cap?

CVRx, Inc. has a market capitalization of $37.83M.

Does CVRX pay a dividend?

CVRx, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does CVRX carry?

CVRx, Inc. has a debt-to-equity ratio of 2.98. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is CVRX's profit margin?

CVRx, Inc. reports a net profit margin of -84.93% — the share of revenue left after every cost, including tax and interest.

What sector is CVRX in?

CVRx, Inc. is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is CVRX listed on?

CVRx, Inc. trades on NMS under the ticker CVRX.

What is CVRX's 52-week range?

Over the last year CVRx, Inc. has traded between $1.27 and $11.30.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens CVRX currently matches

On the figures above, CVRx, Inc. passes the filters for 2 of our ready-made screens, among them Penny Stocks, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksNano Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.